Polar Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-600,425
| Closed | -$25.8M | – | 282 |
|
|
2018
Q4 | $25.8M | Buy |
600,425
+318,601
| +113% | +$13.7M | 0.28% | 116 |
|
|
2018
Q3 | $13.9M | Buy |
+281,824
| New | +$13.9M | 0.12% | 168 |
|
|
2017
Q1 | – | Sell |
-25,000
| Closed | -$808K | – | 262 |
|
|
2016
Q4 | $808K | Sell |
25,000
-9,100
| -27% | -$294K | 0.01% | 242 |
|
|
2016
Q3 | $1.17M | Sell |
34,100
-14,096
| -29% | -$482K | 0.02% | 229 |
|
|
2016
Q2 | $1.63M | Buy |
48,196
+22,162
| +85% | +$748K | 0.03% | 230 |
|
|
2016
Q1 | $1.38M | Buy |
26,034
+5,045
| +24% | +$267K | 0.03% | 228 |
|
|
2015
Q4 | $1.61M | Buy |
20,989
+6,099
| +41% | +$468K | 0.03% | 223 |
|
|
2015
Q3 | $612K | Sell |
14,890
-20,030
| -57% | -$823K | 0.01% | 255 |
|
|
2015
Q2 | $2.47M | Buy |
34,920
+27,767
| +388% | +$1.96M | 0.05% | 217 |
|
|
2015
Q1 | $636K | Buy |
7,153
+2,066
| +41% | +$184K | 0.01% | 264 |
|
|
2014
Q4 | $451K | Buy |
+5,087
| New | +$451K | 0.01% | 260 |
|
|
2014
Q2 | – | Sell |
-197,091
| Closed | -$13.8M | – | 279 |
|
|
2014
Q1 | $13.8M | Sell |
197,091
-109,453
| -36% | -$7.66M | 0.32% | 116 |
|
|
2013
Q4 | $17.6M | Sell |
306,544
-53,875
| -15% | -$3.1M | 0.42% | 82 |
|
|
2013
Q3 | $17.3K | Sell |
360,419
-18,299
| -5% | -$880 | 0.46% | 67 |
|
|
2013
Q2 | $11M | Buy |
+378,718
| New | +$11M | 0.38% | 109 |
|